Clinical Trials on Tyrosinemia Type 2

Total 57256 results

Vitaflo International, Ltd

Completed

Evaluation of TYR Sphere

Alkaptonuria | Tyrosinemias | Tyrosinemia, Type I | Tyrosinemia, Type II | Tyrosinemia, Type III

United Kingdom
metaX Institut fuer Diatetik GmbH
Great Ormond Street Hospital for Children NHS Foundation Trust; Birmingham...

Not yet recruiting

Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies (ZeroMinisMR)

Alkaptonuria | Homocystine; Metabolic Disorder | Tyrosinemia, Type I | Tyrosinemia, Type II | Tyrosinemia, Type III | MSUD (Maple Syrup Urine Disease)
Yassin Abdelghaffar Charity Center for Liver Disease...
Society of Friends of Liver Patients in the Arab World (SLPAW)

Recruiting

Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)

Hereditary Tyrosinemia, Type I

Egypt
Cycle Pharmaceuticals Ltd.
Parexel

Completed

Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)

Hereditary Tyrosinemia, Type I

South Africa
Swedish Orphan Biovitrum

Completed

Taste and Palatability of Orfadin Suspension

Hereditary Tyrosinemia, Type I

Germany, United Kingdom, France
Cycle Pharmaceuticals Ltd.
Parexel

Completed

Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin

Hereditary Tyrosinemia, Type I

South Africa
Swedish Orphan Biovitrum

Completed

Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1 (HT-1)

Hereditary Tyrosinemia, Type I

Belgium, Denmark, France, Germany, Sweden
Swedish Orphan Biovitrum

Completed

Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care (OPAL)

Hereditary Tyrosinemia, Type I

Belgium, Denmark, France, Germany, Austria, Czechia, Finland, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
Cycle Pharmaceuticals Ltd.
Parexel

Completed

Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)

Hereditary Tyrosinemia, Type I

South Africa
National Center for Research Resources (NCRR)
University of Michigan

Completed

Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type I

Tyrosinemia, Type I
Swedish Orphan Biovitrum

Recruiting

A Non-interventional, Post-Marketing Study to Describe Outcome of Nitisinone Treatment in HT-1 Patients

Hereditary Tyrosinemia, Type I

China
University of Washington

Completed

Study of NTBC for Tyrosinemia I

Tyrosinemia I

United States, Canada
CENTOGENE GmbH Rostock

Withdrawn

Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin) (BioTyrosin)

Metabolic Disorders | Tyrosinosis | Hepatorenal Tyrosinemia | Fumarylacetoacetase Deficiency | Fah Deficiency

Germany, Sri Lanka, India
Sutphin Drugs

Unknown

Bio Equivalency 20 Mgm Orfadin and 20 Mgm of Nitisonine (Orfadin)

Hereditary Tyrosinemia, Type I

India
Vitaflo International, Ltd

Recruiting

Evaluation of the Express Plus Range (express plus)

Phenylketonurias | PKU | Maple Syrup Urine Disease | Homocystinuria | Glutaric Acidemia I | Hereditary Tyrosinemia

United Kingdom
Nutricia UK Ltd

Completed

GMP Case Studies of Tolerance, Safety and Acceptability in PKU and TYR

PKU | Tyrosinemias

United Kingdom
Vitaflo International, Ltd

Active, not recruiting

Evaluation of TYR Sphere in France (TYR sphere Fra)

Tyrosinemia | AKU

France
Mathias Ried-Larsen

Unknown

The Effects of Different Doses of Exercise on Pancreatic β-cell Function in Patients With Newly Diagnosed Type 2 Diabetes (DOSE-EX)

Diabetes Mellitus, Type 2 | Type 2 Diabetes Mellitus | Type2 Diabetes | Type2 Diabetes Mellitus

Denmark
Northern Care Alliance NHS Foundation Trust
Brighter AB

Completed

Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation (ADMSUK01)

Diabetes type1 | Diabetes type2

United Kingdom
Hanmi Pharmaceutical Company Limited

Unknown

Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus

Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

United States
Eli Lilly and Company

Active, not recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2D

United States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
Chinese University of Hong Kong

Completed

Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM

Type 2 Diabetes Mellitus | Type2 Diabetes | Obese

Hong Kong
Leiden University Medical Center
Andaluz Health Service

Completed

"POWER2DM Evaluation Campaign" (POWER2DMEC)

Diabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes Mellitus

Netherlands, Spain
Insulet Corporation
Jaeb Center for Health Research

Completed

OP5-005 Using Omnipod 5 in Adults With Type 2 (SECURE-T2D)

Type2 Diabetes

United States
Clinical Research Centre, Malaysia
Ministry of Health, Malaysia

Completed

Effectiveness of PICC Improving HBA1C and Knowledge in Diabetes Mellitus Education (EPICCIHKDMEP)

Diabetes Mellitus | Type2 Diabetes

Malaysia
Chungbuk National University Hospital

Completed

Head-to-head Comparison of Empagliflozin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
ValoTec
APHP

Terminated

Data Acquisition Study in Inadequately Balanced Patients With Type 2 Diabetes Mellitus

Type2 Diabetes

France
Chong Kun Dang Pharmaceutical

Completed

Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus (DISCOVERY)

Type2 Diabetes

Korea, Republic of
National Taipei University of Nursing and Health...
Chiayi Christian Hospital

Completed

Effects of the Insulin Self Titration Education for Type 2 Diabetes Mellitus Patients (ISTE)

Type2 Diabetes
Istanbul Medeniyet University

Completed

The Effect of Fasting on Serum Osmolarity in Diabetic Patients

Type2 Diabetes

Turkey
Arizona State University

Completed

An Alternative Approach to Improve Hyperglycemia Among Type 2 Diabetes Patients

Type2 Diabetes
Yanbing Li

Recruiting

Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification (ESTIMATOR)

Diabetes type2

China
Mondelēz International, Inc.
Centre de Recherche en Nutrition Humaine Rhone-Alpe; Biofortis Mérieux NutriSciences

Recruiting

Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients

Type2 Diabetes

France
Penn State University

Completed

Almond Butter and Fasting Glucose

Type2 Diabetes

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Type2 Diabetes

Korea, Republic of
Faculty of Medical Sciences, Clinical Hospital

Completed

Effects of Yogurt With Probiotics in Adults With Type 2 Diabetes Mellitus

Type2 Diabetes

Spain
Savvysherpa, Inc.

Completed

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3) (CGM_IRB-3)

Type2 Diabetes

United States
Tel-Aviv Sourasky Medical Center

Unknown

16-week Flexible vs. 8-week Semaglutide Titration

Diabetes type2

Israel
Mondelēz International, Inc.
Centre de Recherche en Nutrition Humaine Rhone-Alpe; Biofortis Mérieux NutriSciences

Completed

Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2D Patients

Type2 Diabetes

France
Centro de Estudios en Alimentación y Nutrición,...

Completed

Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics

Type2 Diabetes

Chile
ALI KAMAL M. SAMI

Completed

Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients.

Type2 Diabetes
AJU Pharm Co., Ltd.

Completed

Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150

Diabetes type2

Korea, Republic of
National University of Singapore

Completed

Collaborative Care Model on Type 2 Diabetic Patients

Type2 Diabetes

Singapore
Weill Cornell Medical College in Qatar
Novo Nordisk A/S

Terminated

Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan

Type2 Diabetes

Qatar
Hospices Civils de Lyon

Completed

Triglyceride Rich Lipoproteins and Platelet Activation in Type 2 Diabetes (COMPLETE)

Type2 Diabetes

France
Nanjing First Hospital, Nanjing Medical University

Unknown

Effects of Replacing Lantus With Basalin on the Glycemic Variation in Patients With Type 2 Diabetes Mellitus

Type2 Diabetes

China
Savvysherpa, Inc.

Completed

Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics (CGM_IRB2)

Type2 Diabetes

United States
VitNovo, Inc.

Completed

DCB-DM101 in Healthy Volunteers and for Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Taiwan
Qianfoshan Hospital

Completed

Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy

Type2 Diabetes

China

Clinical Trials on Tyrosinemia Type 2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations